82 related articles for article (PubMed ID: 1926871)
1. Kinetic analysis.
Blomqvist G
Wien Klin Wochenschr; 1991; 103(15):451-7. PubMed ID: 1926871
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two compartmental models for describing receptor ligand kinetics and receptor availability in multiple injection PET studies.
Morris ED; Alpert NM; Fischman AJ
J Cereb Blood Flow Metab; 1996 Sep; 16(5):841-53. PubMed ID: 8784229
[TBL] [Abstract][Full Text] [Related]
3. Quantitative evaluation of benzodiazepine receptors in live Papio papio baboons using positron emission tomography.
Brouillet E; Chavoix C; Khalili-Varasteh M; Bottlaender M; Hantraye P; Yorke JC; Maziere M
Mol Pharmacol; 1990 Oct; 38(4):445-50. PubMed ID: 2172764
[TBL] [Abstract][Full Text] [Related]
4. Kinetic evaluation of positron-emitting muscarinic receptor ligands employing direct intracarotid injection.
Buck A; Mulholland GK; Papadopoulos SM; Koeppe RA; Frey KA
J Cereb Blood Flow Metab; 1996 Nov; 16(6):1280-7. PubMed ID: 8898702
[TBL] [Abstract][Full Text] [Related]
5. Brain radioligands--state of the art and new trends.
Halldin C; Gulyás B; Langer O; Farde L
Q J Nucl Med; 2001 Jun; 45(2):139-52. PubMed ID: 11476163
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic considerations in the PET and SPECT evaluation of CNS receptors.
Mazière B; Delforge J
Q J Nucl Med; 1997 Jun; 41(2):119-26. PubMed ID: 9203851
[TBL] [Abstract][Full Text] [Related]
7. Neuroreceptor quantitation in vivo by the steady-state principle using constant infusion or bolus injection of radioactive tracers.
Lassen NA
J Cereb Blood Flow Metab; 1992 Sep; 12(5):709-16. PubMed ID: 1506439
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography displacement sensitivity: predicting binding potential change for positron emission tomography tracers based on their kinetic characteristics.
Morris ED; Yoder KK
J Cereb Blood Flow Metab; 2007 Mar; 27(3):606-17. PubMed ID: 16788713
[TBL] [Abstract][Full Text] [Related]
9. [The receptor binding study in vivo].
Inoue O; Kobayashi K
Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Aug; 14(4):215-25. PubMed ID: 7975926
[TBL] [Abstract][Full Text] [Related]
10. Assessment of dynamic neurotransmitter changes with bolus or infusion delivery of neuroreceptor ligands.
Endres CJ; Carson RE
J Cereb Blood Flow Metab; 1998 Nov; 18(11):1196-210. PubMed ID: 9809509
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography compartmental models.
Gunn RN; Gunn SR; Cunningham VJ
J Cereb Blood Flow Metab; 2001 Jun; 21(6):635-52. PubMed ID: 11488533
[TBL] [Abstract][Full Text] [Related]
12. Radioligand-binding methods for membrane preparations and intact cells.
Bylund DB; Deupree JD; Toews ML
Methods Mol Biol; 2004; 259():1-28. PubMed ID: 15250483
[TBL] [Abstract][Full Text] [Related]
13. Concept of reaction volume in the in vivo ligand-receptor model.
Delforge J; Syrota A; Bendriem B
J Nucl Med; 1996 Jan; 37(1):118-25. PubMed ID: 8543980
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: modeling strategies.
Ginovart N; Wilson AA; Meyer JH; Hussey D; Houle S
J Cereb Blood Flow Metab; 2001 Nov; 21(11):1342-53. PubMed ID: 11702049
[TBL] [Abstract][Full Text] [Related]
15. Kinetic modeling of 11C-SB207145 binding to 5-HT4 receptors in the human brain in vivo.
Marner L; Gillings N; Comley RA; Baaré WF; Rabiner EA; Wilson AA; Houle S; Hasselbalch SG; Svarer C; Gunn RN; Laruelle M; Knudsen GM
J Nucl Med; 2009 Jun; 50(6):900-8. PubMed ID: 19470850
[TBL] [Abstract][Full Text] [Related]
16. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of halogenated naphthyridone carboxamides as potential ligands for in vivo imaging studies of substance P receptors.
Bagot-Guéret C; Le Bas MD; Tymciu S; Darabantu M; Emond P; Guilloteau D; Lasne MC; Wijkhuisen A; Barré L; Perrio C
Bioconjug Chem; 2003; 14(3):629-41. PubMed ID: 12757389
[TBL] [Abstract][Full Text] [Related]
18. Strategy for the measurement of regional cerebral blood flow using short-lived tracers and emission tomography.
Alpert NM; Eriksson L; Chang JY; Bergstrom M; Litton JE; Correia JA; Bohm C; Ackerman RH; Taveras JM
J Cereb Blood Flow Metab; 1984 Mar; 4(1):28-34. PubMed ID: 6607259
[TBL] [Abstract][Full Text] [Related]
19. An introduction to PET and SPECT neuroreceptor quantification models.
Ichise M; Meyer JH; Yonekura Y
J Nucl Med; 2001 May; 42(5):755-63. PubMed ID: 11337572
[TBL] [Abstract][Full Text] [Related]
20. Lithiation of functionalized fluoroquinolines: synthesis of dihalo-2-phenylquinoline-4-carboxamides and in vitro evaluation as NK-3 receptor ligands for medical imaging studies.
Bennacef I; Tymciu S; Dhilly M; Mongin F; Quéguiner G; Lasne MC; Barré L; Perrio C
J Org Chem; 2004 Apr; 69(7):2622-5. PubMed ID: 15049675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
